Source: https://patents.google.com/patent/US8131337
Timestamp: 2018-03-18 10:00:34
Document Index: 194804740

Matched Legal Cases: ['Application No. 05778030', 'Application No. 06740479', 'Application No. 05778030', 'Application No. 06740479', 'Application No. 06740479', 'Application No. 1358']

US8131337B2 - Method for monitoring early treatment response - Google Patents
US8131337B2
US8131337B2 US11397877 US39787706A US8131337B2 US 8131337 B2 US8131337 B2 US 8131337B2 US 11397877 US11397877 US 11397877 US 39787706 A US39787706 A US 39787706A US 8131337 B2 US8131337 B2 US 8131337B2
US20060222591A1 (en )
US20060222591A1 true US20060222591A1 (en) 2006-10-05
US8131337B2 true US8131337B2 (en) 2012-03-06
DE08771896T1 (en) * 2007-06-29 2010-10-21 AMAG Pharmaceuticals Inc., Lexington Macrophage enhanced MRI (memrt)
US20060177377A1 (en) 2005-02-08 2006-08-10 Receptomon, Llc. Method for monitoring early treatment response
Clemens et al., Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells, Cell Death and Differentiation, 7: 603-615 (2000).
Daly et al., "Phospholipid Metabollism in Cancer Cells Monitored by 31P NMR Spectroscopy", The Journal of Biological Chemistry, 262(31): 14875-14878 (Nov. 5, 1987).
Daly et al., Phospholipid Metabolism in Cancer Cells Monitored by P31 NMR Spectroscopy, Nov. 5, 1987, The Journal of Biological Chemistry, 262(31), pp. 14875-14878. *
Danielsen et al., Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases, Marcel Dekker, Inc. Ch.3: The clinical significance of metabolites, 23-43 (1999).
European Patent Office, extended European Search Report relative to cognate European Patent Application No. 05778030.6, mailed Mar. 3, 2010.
European Patent Office, extended European Search Report relative to related European Patent Application No. 06740479.8, mailed Sep. 17, 2009.
European Patent Office, Office Communication relative to cognate European Patent Application No. 05778030.6, mailed Jun. 14, 2010.
European Patent Office, Office Communication relative to related European Patent Application No. 06740479.8, mailed Apr. 18, 2011.
European Patent Office, Office Communication relative to related European Patent Application No. 06740479.8, mailed Dec. 8, 2009.
Fujimoto et al., "A new immunological parameter predicting the efficacy of cancer therapy", Editorial, Annals of Cancer Research and Therapy, 7(2) (Title Only).
Gerdes, J. et al., Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation, Int. Journal Cancer, 31: 13-20, 1983.
Indian Patent Office, Examination Report relative to related Indian Patent Application No. 1358/MUMNP/2007, mailed Nov. 23, 2010.
International Searching Authority, "International search report" and "Written opinion of the International Searching Authority," for related International Application No. PCT/US05/27060, mailed Jan. 24, 2007.
International Searching Authority, "International search report" and "Written opinion of the International Searching Authority," for related International Application No. PCT/US06/02675, mailed Sep. 21, 2006.
International Searching Authority; International Search Report and Written Opinion relative to International Application No. PCT/US06/012469 mailed Mar. 13, 2007.
Lindskog et al., Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma, Journal of the National Cancer Institute, 96 (19): 1457-1466 (2004).
Maiuri et al., Self-eating and self-killing: crosstalk between autophagy and apoptosis, Nature Reviews/Molecular Cell Biology, 8: 741-752 (Sep. 2007).
Meisamy et al., Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo 1H MR spectroscopy—a pilot study at 4 T1, Radiology, 233: 424-431 (2004).
Mohamad et al., Mitochondrial apoptotic pathways, Biocell, 29(2): 149-161 (2005).
Nakagami et al., "Increased Choline Kinase Activity and Elevated Phosphocholine Levels in Human Colon Cancer," Jpn. J. Cancer Res, 90, 419-424, Apr. 1999.
Neeman, M. et al., Early estrogen-induced metabolic changes and their inhibition by actinomycin D and cycloheximide in human breast cancer cells: 31P and 13C NMR studies, Proc. Natl. Acad. Sci. USA, 86: 5585-5589, Jul. 1989.
Schmitt et al., Apoptosis and therapy, Journal of Pathology, 187: 127-137 (1999).
Schneider-Poetsch, T. et al., Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin, Nat Chem Biol, Mar. 2010, 6(3): 209-217.
Scott et al., 13C-NMR investigation of protein synthesis during apoptosis in human leukemic cell lines, Journal of Cellular Physiology, 181: 147-152 (1999).
Shaffer et al., XBP1, downstream of blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation, Immunity, 21: 81-93 (Jul. 2004).
Sobell, Henry M., Actinomycin and DNA transcription, Proc. Natl. Acad. Sci. USA, Aug. 1985, 82: 5328-5331.
U.S. Appl. No. 11/053,059, filed Feb. 8, 2005, Norfray.
USPTO, Office Action relative to related U.S. Appl. No. 10/946,741 (now U.S. Patent No. 7,289,840), mailed Jan. 11, 2007.
USPTO, Office Action relative to related U.S. Appl. No. 10/946,741 (now U.S. Patent No. 7,289,840), mailed Jun. 14, 2006.
USPTO, Office Action relative to related U.S. Appl. No. 11/053,059 (now U.S. Patent No. 7,622,102), mailed Jun. 15, 2009.
USPTO, Office Action relative to related U.S. Appl. No. 11/193,037 (now abandoned), mailed Jan. 26, 2007.
USPTO, Office Action relative to related U.S. Appl. No. 11/193,037 (now abandoned), mailed Sep. 11, 2007.
USPTO, Office Action relative to related U.S. Appl. No. 11/576,198, mailed Jul. 14, 2011.
USPTO, Office Action relative to related U.S. Appl. No. 11/576,198, mailed Mar. 31, 2011.
USPTO, Office Action relative to related U.S. Appl. No. 11/576,198, mailed Oct. 15, 2010.
USPTO, Office Action relative to related U.S. Appl. No. 11/622,321 (now U.S. patent No. 7,771,706), mailed Mar. 1, 2010.
USPTO, Office Action relative to related U.S. Appl. No. 11/622,321 (now U.S. patent No. 7,771,706), mailed Sep. 14, 2009.
Wojtukiewicz, M. et al., Contribution of the hemostatic system to angiogenesis in cancer, Semin. Thrombosis. Hemost., 30(1): 5-20, Nov. 1, 2004.
US20060222591A1 (en) 2006-10-05 application
Auer et al. 2000 Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study
Graves et al. 2001 Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery
Rodrigues et al. 2014 Magnetic resonance imaging of tumor glycolysis using hyperpolarized 13 C-labeled glucose
Cannistraro et al. 2007 A diffusion tensor imaging study of white matter in obsessive–compulsive disorder